QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Does Science Discriminate against Women ?

This study uses data from the Survey of Doctorate Recipients to evaluate differences in employment outcomes for academic scientists by gender. A decomposition of estimated salary differences shows that over time, gender salary differences can partly be explained by differences in observable characteristics for faculty at the assistant and associate ranks. Substantial gender salary differences f...

متن کامل

Cost-effectiveness analysis of dialysis and kidney transplant in patients with renal impairment using disability adjusted life years in Iran

Background: This cross-sectional study was conducted to compare the cost-effectiveness of three therapeutic methods of long-term hemodialysis, kidney transplant from a living person and kidney transplant from a cadaver utilizing Disability Adjusted Life Years (DALY) using data from the records of patients referred to Afzalipour Hospital of Kerman in 2012.   Methods: This cross-sectional...

متن کامل

Prophylactic implantable cardioverter-defibrillators increased life expectancy with an acceptable cost-effectiveness ratio.

M e t h o d s Design: Cost-effectiveness analysis from a societal perspective using a decision model based on the individual results of 8 randomized controlled trials (RCTs), with follow-up of 16 to 41 months and lifetime extrapolation. Setting: {7 RCTs were done in the United States and 1 in Germany}*. Patients: Patients at risk for sudden death because of left ventricular systolic dysfunction...

متن کامل

Cost-effectiveness Analysis Ofvaccination against Rotavirus with Rix4414 in France

CER was 20 360,90 USD for one patient with viral load <50 copies/ml (16 462,65–41 640,81 USD in sensitivity analysis). Cost of one patient with achieved viral load <50 copies/ml was lower for ETR group. CONCLUSIONS: According to the model ETR seems to be much more effective than placebo with affordable CER incremental ratio. Evaluation of ETR treatment costeffectiveness in common practice in Ru...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2011

ISSN: 1098-3015

DOI: 10.1016/j.jval.2011.02.072